Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prenatal vitamin K1 prophylaxis in women at risk of very preterm birth
ChiCTR2500103096Phase 4Not yet recruiting
- Sponsor
- The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
- Start
- May 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in intracerebral hemorrhage (ICH) and vitamin K deficiency bleeding (VKDB) comparing Prevention group (prenatal vitamin K1) with Control group (no special treatment or placebo) (2 arms). Primary endpoint: Intracranial hemorrhage. Planned start May 2025; status: not yet recruiting.
02
Drugs
phytomenadione
03
Conditions
intracerebral hemorrhage (ICH)vitamin K deficiency bleeding (VKDB)
Beyond the preview
Go deeper on ChiCTR2500103096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500103096.